← Back to headlines
Gilead Sciences to Acquire Arcellx in Strategic Move
Gilead Sciences is reportedly set to acquire Arcellx, a move that would expand Gilead's portfolio and strategic capabilities within the biopharmaceutical sector.
27 Apr, 06:04 — 27 Apr, 06:04
Sources
Showing 1 of 1 sources
Related Stories
NASA Launches Nancy Grace Roman Space Telescope for Cosmic Research
22m ago
Rescued Orangutan Battles Respiratory Illness After Borneo Wildfires
3h ago
NASA Launches Nancy Grace Roman Space Telescope on Planet-Hunting Mission
4h ago
Scientists Investigate Herpes Virus Link to Mass Sardine Die-Off Off South Africa
1d ago